Nuclear Medicine
Assoc. Prof. Burçak YILMAZ
Medical Interests
- Radionuclide Therapies
- PET-CT and PET-MRI Imaging & Reporting
- Conventional Nuclear Medicine Imaging & Reporting (SPECT/CT, Gamma Camera)
Education
- School First Prize - Bahçeşehir College (2000)
- MSc - Faculty of Medicine (Istanbul University-Cerrahpaşa - English Medicine, 2006)
- PhD - Nuclear Medicine (Istanbul University-Cerrahpaşa, 2012)
- PhD - Molecular Oncology (University of Health Sciences, 2018 - Present)
Experience
- Medical Speciality Student - Istanbul University-Cerrahpaşa, Nuclear Medicine USA (2007-2012)
- Specialist Doctor - Nuclear Medicine - Health Sciences University affiliated EAHs (Istanbul) (2012-2020)
- Observer Doctor - University of Washington, Nuclear Medicine Department, Seattle, USA (2017)
- Associate Professor Doctor - Nuclear Medicine - Health Sciences University - Istanbul EAH (March 2020)
- Associate Professor Doctor - Nuclear Medicine (Education and Administrative Responsible) - Health Sciences University - Başakşehir Çam and Sakura City Hospital, Nuclear Medicine Clinic (2020-2022)
- Associate Professor - Nuclear Medicine - Medipol University Bahçelievler Hospital (2022-2023)
- Postdoctoral Scholar - Oregon Health and Science University, Nuclear Medicine Department, Portland, USA (2023-2024)
- Associate Professor - Nuclear Medicine - Biruni University Faculty of Medicine Hospital (2025 - Present)
Languages
- English
- German
- Certificate of Merit award, 2017; Sarcoidosis F-18 FDG PET/CT Imaging and Atypical Presentations; The Radiological Society of North America (RSNA), UNITED STATES.
- Prof. Dr. Suphi Artunkal Award Candidate Paper, 2019; PSMA targeted nuclear robotic surgery: preliminary results; 31st National Nuclear Medicine Congress.
- Prof. Dr. Suphi Artunkal Award Candidate Paper, 2021; Evaluation of interim chemotherapy response with Ga-68 FAPI-46 PET/CT: Preliminary results; 33rd National Nuclear Medicine Congress, TURKEY.
- Prof. Dr. Suphi Artunkal Award Candidate Paper, 2021; Diagnostic success of Ga-68 FAPI-04 PET/CT and F-18 FDG PET/CT in different cancer types; 33. National Nuclear Medicine Congress; TURKEY.
- Best Resident Abstract, Western Regional Chapter of Society of Nuclear Medicine and Molecular Imaging, November 2023; Prediction of Parkinson's Disease rapid progression with machine learning and I-123 Ioflupane SPECT follow up; Vancouver, CANADA.
- Scientific Research Project- University of Health Sciences (2018): The contribution of Tc-99m PSMA SPECT/CT imaging to staging and restaging in patients with prostate cancer, TURKEY.
- Scientific Research Project- University of Health Sciences (2020): Neoadjuvant chemotherapy response evaluation with Ga-68 FAPI PET/CT, TURKEY.
- Yilmaz B, et al. (2019). Effect of external cooling on Lu-177 PSMA uptake for parotid glands. Journal of Nuclear Medicine, 60(10), 1388- 1393. Doi: 10.2967/jnumed.119.226449
Send a Message
Online Appointment
We are one click away with our online appointment system to facilitate your access to our health services.
Call Centre
You can call +90 444 8 276 to contact our experienced patient representatives who are available 24/7.
Treatments
Discover a comprehensive range of advanced treatments tailored to meet diverse healthcare needs.
Technology
Our hospital is equipped with state-of-the-art medical devices, innovative diagnostic tools, and precision treatment systems to deliver exceptional care.
Patient Visits
You can visit your loved ones safely every day between 10.00 and 22.00.
